Dermapharm Holding is a German pharmaceutical company specializing in the production and marketing of off-patent branded pharmaceuticals and healthcare products across a variety of therapeutic areas.
DERMAPHARM HOLDING Sustainability Performance
Climate
0%
Renewable Energy
No data available for DERMAPHARM HOLDING. Target value per method: min. 100%
Greenhouse Gas Emissions
No data available for DERMAPHARM HOLDING. Target value per method: max. 100% of CO₂ budget
Supply Chain
No data available for DERMAPHARM HOLDING. Target value per method: max. 100% of CO₂ budget
Recycling and Recovery of Waste
No data available for DERMAPHARM HOLDING. Target value per method: min. 75%
Society
73%
Union Formation and Collective Bargaining Power
DERMAPHARM HOLDING issues 13,6% collective agreements. Target value per method: min. 80%
CEO Pay Ratio
CEO Hans-Georg Feldmeier earns 18 times the average salary of employees. Target value per method: max. 20 times
Employee Turnover Rate
DERMAPHARM HOLDING has an employee turnover rate of 9,6%. Target value per method: max. 10%
Harassment and Discrimination at the Workplace
DERMAPHARM HOLDING meets 3 quality criteria for handling harassment and discrimination at the workplace. Target value per method: 4 quality criteria
Gender
57%
Women on Board
DERMAPHARM HOLDING has 14,3% women across its top leadership and supervisory bodies. Target value per method: min. 40%
Gender Pay Gap
No data available for DERMAPHARM HOLDING. Target value per method: max. 3%
Women in Management
DERMAPHARM HOLDING employs 48% female managers. Target value per method: min. 40%
Glass Ceiling
The proportion of women in senior management at DERMAPHARM HOLDING is 82,5% of the proportion of women in the overall workforce. Target value per method: min. 90%
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
Renewable Energy
No data available for DERMAPHARM HOLDING. Target value per method: min. 100%
Greenhouse Gas Emissions
No data available for DERMAPHARM HOLDING. Target value per method: max. 100% of CO₂ budget
Supply Chain
No data available for DERMAPHARM HOLDING. Target value per method: max. 100% of CO₂ budget
Waste Recycling
No data available for DERMAPHARM HOLDING. Target value per method: min. 75%
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.
Look at that!
I checked the impact of this company
DERMAPHARM HOLDING
DE000A2GS5D8
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
powered by
www.moneycare.io
Compare DERMAPHARM HOLDING with ...
DERMAPHARM HOLDING
?
Impact Score
Climate
Society
Gender
0%
73%
57%
0%
0%
0%
DERMAPHARM HOLDING
?
Impact Score
Climate
Renewable Energy
—
Greenhouse Gas Emissions
—
Supply Chain
—
Waste Recycling
—
Society
Collective Agreements
17%
CEO Pay Ratio
100%
Employee Turnover Rate
100%
Anti-Discrimination
75%
Gender
Women on Board
36%
Gender Pay Gap
—
Women in Management
100%
Glass Ceiling
92%
Sources of sustainability performance
Metric
Value
Unit
Year
PDF Name
PDF Page
No sources found.
Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.